ClinicalTrials.Veeva

Menu

Clinical Investigation on the Effects of a Vegetable Juice Treatment

University of California (UC) Davis logo

University of California (UC) Davis

Status and phase

Completed
Phase 1

Conditions

Vegetables
Blood Pressure
Cardiovascular Disease

Treatments

Other: Vegetable Juice

Study type

Interventional

Funder types

Other

Identifiers

NCT01161706
200614971

Details and patient eligibility

About

The purpose of the investigators study is to investigate the impact of a commercial vegetable juice on dietary vegetable intake and select cardiovascular risk factors in a generally healthy population. The study was a 12 week study with 3 groups who received 0, 8 or 16 fluid ounces daily of vegetable juice, along with education on the DASH (Dietary Approaches to Stop Hypertension) diet. All participants came in for 3 study visits at 0, 6 and 12 weeks into the study.

Enrollment

90 patients

Sex

All

Ages

40 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

***Inclusion Criteria***

  • Age 40 to 65 yrs
  • Subject's body mass index is between 18.5 - 34.9 kg/m2
  • Subject is willing and able to comply with the study protocols
  • Subject is willing to consume a vegetable-based beverage daily for three months

***Exclusion Criteria***

  • Physical signs of health impairment
  • Uncontrolled diabetes or hypertension
  • Pregnant or lactating
  • Active tuberculosis or lung disease (i.e. COPD)
  • Renal or Liver disease
  • Heart Disease, which includes Cardiovascular events and Stroke
  • Cushing's syndrome
  • Exercise trained individuals
  • History of psychiatric disorders i.e. schizophrenia or bi-polar or depression treated with antidepressants within the last 1 year
  • Anxiety medications
  • Use of MAOI inhibitors within the last 1 year (e.g., phenelzine (Nardil), tranylcypromine (Parnate), etc.)
  • Quality of life score of 21 or above
  • Routine use of prescription drugs or over-the counter medications, which may potentially modulate the outcome of this study; including antibiotics, aspirin and aspirin-containing formulations, COX-2 inhibitors, antihistamines, corticosteroids, erectile dysfunction drugs
  • Asthma (can be worsened by mild to moderate food allergies)
  • Indications of substance or alcohol abuse within the last 3 years
  • The volunteer is undergoing nicotine cessation therapy
  • Laboratory values outside the reference range if determined to be clinically significant by Dr. M. Eric Gershwin
  • Individuals with known salt-sensitive hypertension
  • History of stage 1 high blood pressure defined as systolic > 140 and diastolic > 90, with or without use of HTN medications
  • Multi-Vitamin use other than a One-A-Day essential
  • Use of herbal or plant-based supplements; omega-3 fatty acids, and fish oils and unwilling to discontinue use while participating in the study
  • Allergies to vegetables

Trial design

90 participants in 3 patient groups

Control
No Intervention group
Description:
0 fluid ounces vegetable juice plus dietary education on the DASH (Dietary Approaches to Stop Hypertension) diet
8 fluid ounces vegetable juice
Experimental group
Description:
8 fluid ounces vegetable juice plus dietary education on the DASH (Dietary Approaches to Stop Hypertension) diet
Treatment:
Other: Vegetable Juice
16 fluid ounces vegetable juice
Experimental group
Description:
16 fluid ounces vegetable juice plus dietary education on the DASH (Dietary Approaches to Stop Hypertension) diet
Treatment:
Other: Vegetable Juice

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems